+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rivastigmine"

From
From
From
Alzheimer's Disease Market and Forecast Analysis 2034 - Product Thumbnail Image

Alzheimer's Disease Market and Forecast Analysis 2034

  • Drug Pipelines
  • February 2019
  • 300 Pages
  • Global
From
From
Analyzing the Global CNS Market 2018 - Product Thumbnail Image

Analyzing the Global CNS Market 2018

  • Report
  • April 2018
  • Global
From
Alzheimer Disease Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Alzheimer Disease Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 111 Pages
  • China
From
Global Parkinson's Drug Market & Clinical Trial Insight 2025 - Product Thumbnail Image

Global Parkinson's Drug Market & Clinical Trial Insight 2025

  • Clinical Trials
  • January 2020
  • 500 Pages
  • Global
From
From
From
From
Alzheimer Disease Drugs Markets in China - Product Thumbnail Image

Alzheimer Disease Drugs Markets in China

  • Report
  • November 2023
  • 239 Pages
  • China
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

  • Report
  • November 2021
  • 575 Pages
  • Global
From
From
Loading Indicator

Rivastigmine is a drug used to treat symptoms of Alzheimer's disease and other forms of dementia. It is a cholinesterase inhibitor, meaning it works by increasing the amount of a chemical messenger in the brain that helps nerve cells communicate with each other. It is used to treat mild to moderate dementia caused by Alzheimer's disease or Parkinson's disease. It is also used to treat mild to moderate dementia caused by Lewy body dementia. Rivastigmine is available in both capsule and patch form. Rivastigmine is part of the Central Nervous System (CNS) drugs market, which includes drugs used to treat neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. CNS drugs are used to treat a wide range of conditions, from mild to severe. The CNS drugs market is highly competitive, with many companies offering similar products. Some companies in the Rivastigmine market include Novartis, Pfizer, Mylan, and Teva Pharmaceuticals. Show Less Read more